Testosterone propionate/testosterone enanthate/testosterone undecylenate

{{Short description|Combination drug}}

{{Drugbox

| type = combo

| drug_name = TP/TE/TUe

| component1 = Testosterone propionate

| class1 = Androgen; Anabolic steroid

| component2 = Testosterone enanthate

| class2 = Androgen; Anabolic steroid

| component3 = Testosterone undecylenate

| class3 = Androgen; Anabolic steroid

| tradename = Durasteron

| Drugs.com =

| MedlinePlus =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration = Intramuscular injection

| CAS_number =

| ATC_prefix =

| ATC_suffix =

| PubChem =

| DrugBank =

| synonyms = TP/TE/TUe

}}

Testosterone propionate/testosterone enanthate/testosterone undecylenate (TP/TE/TUe), sold under the brand name Durasteron, is an injectable combination medication of testosterone propionate (TP), testosterone valerate (TV), and testosterone undecylenate (TUe), all of which are androgens/anabolic steroids. It contains 20 mg TP, 80 mg TE, and 150 mg TUe (for a total of 250 mg testosterone ester and 169.5 mg free testosterone) in oil solution and is administered by intramuscular injection at regular intervals, for instance once every 3 or 4 weeks.{{cite journal| vauthors = Joël CA |title=Zur Behandlung männlicher Fertilitätsstörungen mit hohen Androgendosen|trans-title=For the treatment of male fertility disorders with high androgen doses|journal=Gynecologic and Obstetric Investigation|volume=150|issue=3|year=1960|pages=149–156|issn=1423-002X|doi=10.1159/000305737|quote=[...] 20 mg Testosteronpropionat, 80 mg Testosteronheptanoat, 150 mg Testosteronundecylat (Durasteron Teva) [...] }}{{cite book| vauthors = Arends G, Zörnig H, Hager H, Frerichs G, Kern W |title=Hagers Handbuch der pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Drogisten, Ärzte u. Medizinalbeamte|url=https://books.google.com/books?id=8bLwBgAAQBAJ&pg=PA1145|date=14 December 2013|publisher=Springer-Verlag|isbn=978-3-662-36329-4|pages=1145–|quote=At the same time, treatment with a long-acting testosterone preparation (Durasteron®) was instituted, with one injection given every four weeks.}}{{cite journal | vauthors = Spitz IM, Hirsch HJ, Landau H, Zylber-Haran E, Gross V, Rachmilewitz EA | s2cid = 20319052 | title = TSH secretion in thalassemia | journal = Journal of Endocrinological Investigation | volume = 7 | issue = 5 | pages = 495–9 | date = October 1984 | pmid = 6439771 | doi = 10.1007/BF03348456 | quote = The male patients were given a long acting tes- tosterone preparation (Durasteron, Teva) 250 mg by im injection every 3 weeks for a total of 8 injections. }} Use of Durasteron by bodybuilders has been reported.{{cite journal | vauthors = Daher EF, Silva Júnior GB, Queiroz AL, Ramos LM, Santos SQ, Barreto DM, Guimarães AA, Barbosa CA, Franco LM, Patrocínio RM | s2cid = 23319246 | display-authors = 6 | title = Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review | journal = International Urology and Nephrology | volume = 41 | issue = 3 | pages = 717–23 | year = 2009 | pmid = 19387860 | doi = 10.1007/s11255-009-9571-8 }}{{cite journal | vauthors = Davani-Davari D, Karimzadeh I, Khalili H | title = The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review | journal = BMC Nephrology | volume = 20 | issue = 1 | pages = 198 | date = May 2019 | pmid = 31151420 | doi = 10.1186/s12882-019-1384-0 | pmc = 6545019 | doi-access = free }}

{{Parenteral durations of androgens/anabolic steroids}}